APA (7th ed.) Citation

Marißen, J., Hudalla, H., & Bork, P. (2019). Efficacy of Bifidobacterium longum, B. infantis and Lactobacillus acidophilus probiotics to prevent gut dysbiosis in preterm infants of 28+0-32+6 weeks of gestation: A randomised, placebo-controlled, double-blind, multicentre trial : the PRIMAL Clinical Study protocol. BMJ open, 9(11), . https://doi.org/10.1136/bmjopen-2019-032617

Chicago Style (17th ed.) Citation

Marißen, Janina, Hannes Hudalla, and Peer Bork. "Efficacy of Bifidobacterium Longum, B. Infantis and Lactobacillus Acidophilus Probiotics to Prevent Gut Dysbiosis in Preterm Infants of 28+0-32+6 Weeks of Gestation: A Randomised, Placebo-controlled, Double-blind, Multicentre Trial : The PRIMAL Clinical Study Protocol." BMJ Open 9, no. 11 (2019). https://doi.org/10.1136/bmjopen-2019-032617.

MLA (9th ed.) Citation

Marißen, Janina, et al. "Efficacy of Bifidobacterium Longum, B. Infantis and Lactobacillus Acidophilus Probiotics to Prevent Gut Dysbiosis in Preterm Infants of 28+0-32+6 Weeks of Gestation: A Randomised, Placebo-controlled, Double-blind, Multicentre Trial : The PRIMAL Clinical Study Protocol." BMJ Open, vol. 9, no. 11, 2019, https://doi.org/10.1136/bmjopen-2019-032617.